COMMUNIQUÉS West-GlobeNewswire

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
28/03/2024
Enrolled 12 participants in Phase 2 BESTOW trial evaluating tegoprubart for the prevention of kidney rejection Tegoprubart used as a component of the immunosuppressive treatment regimen following the first-ever [...]
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
28/03/2024
Publication of annual report for financial year 2023 Annual Shareholders’ Meeting resolutions include approval of revised Remuneration Policy and (re)appointment of Board members Extraordinary Shareholders’ Meeting [...]
Spectral Medical Announces Fourth Quarter and Fiscal 2023 Results and Provides Corporate Update
28/03/2024
97 patients enrolled TORONTO, March 28, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock [...]
Dyadic Reports 2023 Full Year Results and Recent Company Progress
28/03/2024
Closed a $6.0 million convertible note in a private placement, with a conversion price of $1.79 and no warrants Reported positive topline data from First-In-Human Phase 1 trial demonstrated clinical safety and antibody [...]
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
28/03/2024
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – March 28, 2024 – 07:00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, [...]
Civitas Networks for Health to Host 2024 Annual Conference in Detroit This October
28/03/2024
'Bridging Data and Doing’, data-informed community-led strategies for continued health improvement WASHINGTON, March 28, 2024 (GLOBE NEWSWIRE) -- Civitas Networks for Health today announced its 2024 Annual Conference [...]
UPDATE – Breckenridge Brewery Partners With Denver Nuggets to Launch Championship Edition Mile High City Golden Ale
28/03/2024
A Special Brew Celebrating Denver's Champions with Nostalgic Packaging BRECKENRIDGE, Colo., March 28, 2024 (GLOBE NEWSWIRE) -- Breckenridge Brewery ("Breckenridge" or the "Brewery"), a pioneer in Colorado's craft beer [...]
Milestone Scientific Schedules 2023 Year-End Financial Results and Business Update Conference Call
28/03/2024
ROSELAND, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that [...]
Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering
28/03/2024
CHATHAM, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a biopharmaceutical company, today announced it has entered into a securities purchase [...]
Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting
28/03/2024
Presentation will address the Company’s clinical data in Parkinson’s disease CAPE CANAVERAL, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX ), a U.S. company pioneering the development of a new [...]
Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update
28/03/2024
Advanced OTX-2002 in MYCHELANGELO™ I trial; initial cohorts demonstrated encouraging disease control rate in late-stage HCC patients Established a research collaboration with Novo Nordisk to develop an epigenomic [...]
Endonovo Closes Asset Purchase Agreement for a Minimum of $50M With SofPulse, Inc
28/03/2024
Los Angeles, CA, March 28, 2024 (GLOBE NEWSWIRE) -- Endonovo (OTC PINK: ENDV) and its subsidiary, SofPulse, Inc., today announced they have finalized and completed the Asset Purchase Agreement (APA), originally signed [...]
Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases
28/03/2024
Planning for proof-of concept Phase 1 investigator-sponsored clinical trial evaluating MB-106 CD20-targeted CAR T-cell therapy in autoimmune diseases is underway and expected to initiate in the fourth quarter of 2024 MB [...]
GRI Bio to Present at the MedInvest Biotech & Pharma Investor Conference
28/03/2024
Live webcast on Wednesday, April 3 rd at 10:10 AM ET LA JOLLA, CA, March 28, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of [...]
Get Ready to Elevate Your Chill Game with Evn's New Hybrid Gummies!
28/03/2024
NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Roll out the green carpet and get your taste buds ready for a delightful new twist in the world of hemp-derived delights—Evn's fresh-off-the-vine Hybrid Gummies are here! The [...]
JenaValve Announces Publication of ALIGN-AR Pivotal Trial Results in The Lancet
28/03/2024
IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced the publication of results from the ALIGN [...]
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
28/03/2024
LEXINGTON, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that its multi-year [...]
TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer
28/03/2024
Medical oncologist brings over 25 years of industry experience to lead Clinical Development Strategy BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company [...]
Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors
28/03/2024
SAN FRANCISCO, March 28, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today announced the [...]

Pages